Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' SPINLER SA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 40 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. El-Beyrouty, C; Spinler, SA
      Cilostazol for prevention of thrombosis and restenosis after intracoronarystenting

      ANNALS OF PHARMACOTHERAPY
    2. Spinler, SA; Hilleman, DE; Cheng, JWM; Howard, PA; Mauro, VF; Lopez, LM; Munger, MA; Gardner, SF; Nappi, JM
      New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines

      ANNALS OF PHARMACOTHERAPY
    3. Mathis, AS; Meswani, P; Spinler, SA
      Risk stratification in non-ST segment elevation acute coronary syndromes with special focus on recent guidelines

      PHARMACOTHERAPY
    4. Inverso, SM; Spinler, SA
      Antithrombotic agents for secondary prevention of cardioembolic and noncardioembolic stroke - Another viewpoint

      PHARMACOTHERAPY
    5. Spinler, SA; Inverso, SM
      Update on strategies to improve thrombolysis for acute myocardial infarction

      PHARMACOTHERAPY
    6. Spinler, SA
      Activated partial thromboplastin time evaluation

      PHARMACOTHERAPY
    7. Spinler, SA; Evans, CM
      Update in unfractionated heparin, low-molecular-weight heparins, and heparinoids in the elderly (Age >= 65 years)

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    8. Nawarskas, JJ; Spinler, SA
      Update on the interaction between aspirin and angiotensin-converting enzyme inhibitors

      PHARMACOTHERAPY
    9. Spinler, SA; Al-Jazairi, AS; Cheng, JWM; Kapoor, S; Kobrin, S; Shaw, L
      Predictive performance study of two digoxin assays in subjects with various degrees of renal function

      THERAPEUTIC DRUG MONITORING
    10. Nawarskas, JJ; Townsend, RR; Cirigliano, MD; Spinler, SA
      Effect of aspirin on blood pressure in hypertensive patients taking enalapril or losartan

      AMERICAN JOURNAL OF HYPERTENSION
    11. Spinler, SA
      Clinical trials of low-molecular-weight heparins in cardiology

      PHARMACOTHERAPY
    12. SPINLER SA; NAWARSKAS JJ
      LOW-MOLECULAR-WEIGHT HEPARINS FOR ACUTE CORONARY SYNDROMES

      The Annals of pharmacotherapy
    13. Spinler, SA; Nawarskas, JJ; Boyce, EG; Connors, TE; Charland, SL; Goldfarb, S
      Predictive performance of ten equations for estimating creatinine clearance in cardiac patients

      ANNALS OF PHARMACOTHERAPY
    14. SPINLER SA; NAWARSKAS JJ; FOOTE EF; SABAPATHI D; CONNORS JE; MARCHLINSKI FE
      CLINICAL PRESENTATION AND ANALYSIS OF RISK-FACTORS FOR INFECTIOUS COMPLICATIONS OF IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR IMPLANTATIONS AT A UNIVERSITY MEDICAL-CENTER

      Clinical infectious diseases
    15. NAWARSKAS JJ; SPINLER SA
      DOES ASPIRIN INTERFERE WITH THE THERAPEUTIC EFFICACY OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS IN HYPERTENSION OR CONGESTIVE-HEART-FAILURE

      Pharmacotherapy
    16. MEISTER FL; STRINGER KA; SPINLER SA; GONZALEZ E; TALBERT RL; WEINER B; GUERRERO RM; SMITH R
      THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION

      Pharmacotherapy
    17. EARL GL; STANEK EJ; SPINLER SA
      INTRAVENOUS NITROGLYCERIN TOLERANCE IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY AND CONGESTIVE-HEART-FAILURE

      Pharmacotherapy
    18. SPINLER SA
      UNFRACTIONATED HEPARIN DOSING IN THE FRIC STUDY

      Circulation
    19. SPINLER SA
      CARDIOVASCULAR DRUG PRESCRIBING PATTERNS - WHERE IS THE EVIDENCE OF IMPROVEMENT

      American journal of managed care
    20. NAWARSKAS JJ; MCCARTHY DM; SPINLER SA
      DIGOXIN TOXICITY SECONDARY TO CLARITHROMYCIN THERAPY

      The Annals of pharmacotherapy
    21. SPINLER SA; MIKHAIL PA
      PREHOSPITAL-INITIATED THROMBOLYSIS

      The Annals of pharmacotherapy
    22. CHENG JWM; CHARLAND SL; SHAW LM; KOBRIN S; GOLDFARB S; STANEK EJ; SPINLER SA
      IS THE VOLUME OF DISTRIBUTION OF DIGOXIN REDUCED IN PATIENTS WITH RENAL DYSFUNCTION - DETERMINING DIGOXIN PHARMACOKINETICS BY FLUORESCENCE POLARIZATION IMMUNOASSAY

      Pharmacotherapy
    23. STANEK EJ; CHENG JWM; PEEPLES PJ; SIMKO RJ; SPINLER SA
      PATIENT PREFERENCES FOR THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL-INFARCTION

      Medical decision making
    24. SPINLER SA; BOSSO J; HAK L; HAMMOND R; KRADJAN W; POIRIER T; WAGNER M
      REPORT OF THE TASK-FORCE CONCERNING BOARD CERTIFICATION REQUIREMENTS FOR PHARMACY PRACTICE FACULTY

      American journal of pharmaceutical education
    25. NAWARSKAS JJ; SPINLER SA
      ADDITIONAL ANTICOAGULANT STRATEGIES FOR MANAGING HEPARIN-INDUCED THROMBOCYTOPENIA

      American journal of health-system pharmacy
    26. HSU I; SPINLER SA
      MORE ON COMPARISON OF HMG-COA REDUCTASE INHIBITORS

      The Annals of pharmacotherapy
    27. SPINLER SA; NAWARSKAS JJ
      ARE THE DRUG NAMES COUMADIN AND WARFARIN INTERCHANGEABLE

      Journal of the American College of Cardiology
    28. HSU I; SPINLER SA; JOHNSON NE
      COMPARATIVE-EVALUATION OF THE SAFETY AND EFFICACY OF HMG-COA REDUCTASE INHIBITOR MONOTHERAPY IN THE TREATMENT OF PRIMARY HYPERCHOLESTEROLEMIA

      The Annals of pharmacotherapy
    29. CHENG JWM; CHARLAND SL; GOLDFARB S; SPINLER SA
      EFFECTS OF RENAL-FUNCTION ON RECAINAM PHARMACOKINETICS AND PHARMACODYNAMICS

      Clinical pharmacology and therapeutics
    30. SPINLER SA; CHENG JWM; KINDWALL KE; CHARLAND SL
      POSSIBLE INHIBITION OF HEPATIC-METABOLISM OF QUINIDINE BY ERYTHROMYCIN

      Clinical pharmacology and therapeutics
    31. PLASTINO KA; CONNORS JE; SPINLER SA
      POSSIBLE SYNERGY BETWEEN AMINOGLYCOSIDES AND VANCOMYCIN IN THE TREATMENT OF STAPHYLOCOCCUS- EPIDERMIDIS ENDOCARDITIS

      The Annals of pharmacotherapy
    32. CHENG JWM; SPINLER SA
      SHOULD ALL PATIENTS WITH DILATED CARDIOMYOPATHY RECEIVE CHRONIC ANTICOAGULATION

      The Annals of pharmacotherapy
    33. SPINLER SA; CZIRAKY MJ
      LIPOPROTEIN(A) - PHYSIOLOGICAL-FUNCTION, ASSOCIATION WITH ATHEROSCLEROSIS, AND EFFECTS OF LIPID-LOWERING DRUG-THERAPY

      The Annals of pharmacotherapy
    34. WITTBRODT ET; SPINLER SA
      PREVENTION OF ANAPHYLACTOID REACTIONS IN HIGH-RISK PATIENTS RECEIVINGRADIOGRAPHIC CONTRAST-MEDIA

      The Annals of pharmacotherapy
    35. STANEK EJ; TUCKER PP; CHENG JWM; SPINLER SA
      PATIENT PREFERENCES OF TPA AND STREPTOKINASE

      Circulation
    36. STANEK EJ; TUCKER PP; CHENG JWM; SPINLER SA
      PATIENT PREFERENCES OF TPA AND STREPTOKINASE

      Circulation
    37. MORALES E; SPINLER SA; CHIN MM; JOZEFIAK E
      CRITERIA FOR USE OF HYPOLIPIDEMIC AGENTS IN ADULTS

      American journal of hospital pharmacy
    38. NICHOLSON CD; MEULEMAN DG; MAGNANI HN; EGBERTS JFM; LEIBOWITZ DA; SPINLER SA; CZIRAKY MJ
      DANAPAROID IS NOT A LOW-MOLECULAR-WEIGHT HEPARIN

      American journal of hospital pharmacy
    39. SPINLER SA; CZIRAKY MJ
      DANAPAROID IS NOT A LOW-MOLECULAR-WEIGHT HEPARIN

      American journal of hospital pharmacy
    40. CZIRAKY MJ; SPINLER SA
      LOW-MOLECULAR-WEIGHT HEPARINS FOR THE TREATMENT OF DEEP-VEIN THROMBOSIS

      Clinical pharmacy


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/10/20 alle ore 06:55:12